Newsletter

The CSMO Way

Q2 has unlocked significant opportunities as we expand our capabilities as a digital CSMO (Contract Sales and Marketing Organization). Combining Docquity’s leading network insights and robust technology solutions, we have brought to market a proven digital commercial model – our Awareness to Advocacy (A2A) program – that drives strong ROIs for clients.

A critical element of our A2A program is Docquity’s Virtual Medical Representatives (VMRs). As clients adapt to reach HCPs in an on-demand world, rapidly evolving audience behaviors and resource limitations continue to pose challenges. Our VMRs offer a winning solution by leveraging actionable insights, pharmaceutical expertise, and digital proficiency to deepen and scale HCP engagements alongside on-ground teams.

We have seen our insights-driven VMRs achieve inspiring business impact for clients:

  • A recent VMR-led multichannel campaign enabled an Oncology client to educate specialists on product safety and efficacy at 17% of the cost of traditional methods.
  • Another client in the pain management sector grew HCP reach by 2.5x and market share by 10% in one year!

These success stories demonstrate the value of our digital CSMO model, and we are excited to forge more commercial partnerships. For a deeper discussion on strengthening your brand performance across Asia, please reach Christophe Meugnier, Vice President of Business Development, Docquity at christophe.meugnier@docquity.com.

Docquity Founders

Share it with
Email
Facebook
LinkedIn
Twitter
WhatsApp

Data Privacy Notice

This Privacy Notice shall be read in conjunction with the Privacy Policy to the extent this Notice does not mention or specify the particulars that should have been mentioned or specified relating to the Notice in pursuance of the provisions of the Data Protection Laws as applicable.

On having accessed or visited this Platform you the Noticee hereby voluntarily consent to and take notice of the fact that the personal data, by which or in relation whereto you the concerned Noticee is identifiable, shall be retained, stored, used, and may be processed by the Company for the purpose and in the manner, though legal, found suitable to it for commercial and/or some other reasons. The detailed specificity whereof may be found in the Privacy Policy. The consent provided herein may be withdrawn anytime by you, the Noticee, at its own volition by removing your profile or by writing to us at support@docquity.com.

As a Noticee, you shall have the right to grievance redressal, in relation to your consent or our use of your personal data, which you may address by writing to us at dpo@docquity.com. Should you, the Noticee, thereafter remain unsatisfied or dissatisfied with the resolution provided by us, you, the Noticee, may approach the concerned regulatory authority for the redressal of your grievance.

Data Privacy Notice

By using this platform, you consent to our use of your personal data as detailed in our Privacy Policy, and acknowledge that we use cookies to improve your browsing experience